Shopify struck a positive note for the second quarter, calling for revenue to grow in mid-twenties percentage rate. According to FactSet consensus, analysts peg revenue to grow to $2.53 billion from ...

TIM's management has missed its guidance targets countless times in recent years, so we remain cautious. On top of a more than EUR 4 billion cash cushion after the divestment of its fixed network, TIM ...

The Bank of England cut rates, highlighting a growing gap in how global central banks and the Federal Reserve are approaching Trump's tariffs. The company agreed to acquire Deribit, a push into the ...

The Labor Department said that 228,000 filed new jobless claims in the week through May 3, down from 241,000 a week earlier. Economists polled by The Wall Street Journal had expected to see 230,000 ...

--On pace for largest percent increase since Oct. 13, 2022, when it rose 4.98% --Down 62.49% from its all-time closing high of $59.02 on April 20, 2022 --Down 34.48% from 52 weeks ago (May 9, 2024), ...

Oil futures pressed higher amid optimism about a U.S. trade deal with the U.K. and planned talks with China. Natural gas futures were up, although near-term fundamentals imply downside risks with mild ...

The Johnson & Johnson spinoff that makes Tylenol and Benadryl, logged earnings growth ahead of expectations, named a new chief financial officer and boosted its sales-growth projection for the year, ...

Disney's parks outside the U.S. are often a bargain compared with its American ones Could a Disney vacation in Abu Dhabi be a bargain compared with the American equivalent? Travelers may think of the ...

As of March 31, we calculate a net debt to adjusted EBITDA ratio of 0.6. Corteva's debt levels will fluctuate throughout the new year due to the seasonal nature of the seed and crop chemicals business ...

Intercontinental Exchange, Inc. (ICE) is currently at $177.80, up $1.27 or 0.72% --Would be new all-time high (Based on available data back to Nov. 16, 2005) --Currently up 13 consecutive days; up ...

Many economists have figured that America's solid productivity improvements in the past decade grew out of a massive agglomeration of tiny tweaks at millions of businesses. In fact, what happens ...

BeiGene aims to be a next-generation oncology innovator by broadening its drug and pipeline portfolio to various solid tumors in addition to blood cancers. As such, it been actively investing to build ...